Cancer Targeted Gene Panel Lung Test
Comprehensive Genetic Analysis for Lung Cancer Treatment
The Cancer Targeted Gene Panel Lung Test represents a breakthrough in personalized medicine for lung cancer patients. This advanced molecular diagnostic test utilizes cutting-edge next-generation sequencing (NGS) technology to analyze specific genetic mutations that drive lung cancer growth and progression. By identifying these genetic alterations, healthcare providers can develop targeted treatment strategies that are specifically tailored to your unique cancer profile.
What This Test Measures and Detects
Our comprehensive lung cancer gene panel examines eight critical genetic markers that play significant roles in lung cancer development and treatment response:
- ALK1 Gene Rearrangements – Detects ALK fusion proteins that respond to targeted therapies
- ROS1 Gene Fusions – Identifies ROS1 rearrangements for specific inhibitor treatments
- MET Amplification – Measures MET gene copy number variations
- MET Mutations – Detects specific MET gene mutations affecting cancer growth
- KRAS Mutations – Identifies KRAS oncogene alterations common in lung cancer
- BRAF Mutations – Detects BRAF gene changes that influence treatment options
- ERBB2 (HER2) Alterations – Identifies HER2 gene amplifications and mutations
- EGFR Mutations – Detects epidermal growth factor receptor mutations for targeted therapy selection
Who Should Consider This Test
This comprehensive genetic testing is particularly beneficial for individuals who:
- Have been newly diagnosed with non-small cell lung cancer (NSCLC)
- Are experiencing progression of existing lung cancer despite current treatment
- Have a family history of lung cancer or genetic predisposition
- Are considering targeted therapy options for advanced lung cancer
- Need treatment guidance for metastatic lung cancer
- Have adenocarcinoma or other NSCLC subtypes
- Are seeking personalized treatment approaches based on genetic markers
Key Benefits of Taking the Cancer Targeted Gene Panel Lung Test
Undergoing this comprehensive genetic analysis provides numerous advantages for lung cancer patients:
- Personalized Treatment Planning – Identifies specific genetic mutations that respond to targeted therapies
- Improved Treatment Outcomes – Helps select the most effective medications for your cancer type
- Reduced Treatment Side Effects – Avoids ineffective treatments and their associated side effects
- Comprehensive Genetic Profile – Provides a complete picture of multiple genetic drivers simultaneously
- Informed Decision Making – Empowers patients and physicians with actionable genetic information
- Advanced Technology – Utilizes state-of-the-art NGS and FISH methodologies for accurate results
- Cost-Effective Approach – Multiple genetic markers analyzed in a single test
Understanding Your Test Results
Your test results will provide detailed information about the genetic mutations detected in your lung cancer tissue. A positive result for specific mutations indicates that targeted therapies may be effective for your treatment. For example:
- EGFR Mutations may respond to EGFR tyrosine kinase inhibitors
- ALK Rearrangements typically respond well to ALK inhibitors
- ROS1 Fusions may benefit from specific ROS1-targeted treatments
- BRAF Mutations could indicate responsiveness to BRAF inhibitors
Your oncologist will review these results with you and discuss how they impact your treatment options. It’s important to remember that genetic testing provides valuable information, but treatment decisions should always be made in consultation with your healthcare team.
Test Pricing and Details
| Test Feature | Details |
|---|---|
| Test Name | Cancer Targeted Gene Panel Lung Test |
| Regular Price | $876 USD |
| Discount Price | $676 USD |
| Turnaround Time | Sample Tuesday by 9 AM; Report in 10 Working Days |
| Sample Type | Formalin Fixed Paraffin Embedded Tissue Block (Room Temperature Shipping) |
| Required Forms | Duly Filled NGS Test Requisition Form (Form 40) |
Nationwide Availability
We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures that advanced genetic testing is accessible to patients nationwide.
Take the Next Step in Your Lung Cancer Journey
Don’t leave your treatment decisions to chance. The Cancer Targeted Gene Panel Lung Test provides the genetic insights needed to make informed decisions about your lung cancer treatment. With our discounted price of $676 USD, advanced genetic testing is more accessible than ever.
Ready to get started? Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or speak with our genetic counseling team. Take control of your lung cancer treatment with personalized genetic insights that can make a real difference in your care journey.
